Hideyuki Tozaki

909 citations
15 papers · 742 indexed · h-index 11
Topics
Advanced Drug Delivery Systems (8 papers)Inflammatory Bowel Disease (5 papers)Drug Solubulity and Delivery Systems (5 papers)
Partner nations
JapanUnited States

In The Last Decade

Hideyuki Tozaki

15 papers receiving 700 citations

Peers

Hideyuki Tozaki
Comparison fields: 5 of 76
  • Pharmaceutical Science 490
  • Molecular Biology 145
  • Biomaterials 118
  • Gastroenterology 111
  • Food Science 99
Replace Akira Terabe with:
Akira Terabe Japan
Junta Komoike Japan
Cao De-ying China
Betty Philip Oman
Supandeep Singh Hallan Italy
Punit P. Shah India
C.M. Savariar Malaysia
Naijing Ye China
Yohko Akiyama Japan
Swarnali Das Paul India
Hideyuki Tozaki relative to Akira Terabe Japan Akira Terabe's profile →
Citations per field
00.5×1.5×
Akira Terabe · 1×
Citations per year

Countries citing papers authored by Hideyuki Tozaki

Since Specialization
Citations

This map shows the geographic impact of Hideyuki Tozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Tozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Tozaki more than expected).

Fields of papers citing papers by Hideyuki Tozaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Tozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Tozaki. The network helps show where Hideyuki Tozaki may publish in the future.

Co-authorship network of co-authors of Hideyuki Tozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Tozaki. A scholar is included among the top collaborators of Hideyuki Tozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Tozaki. Hideyuki Tozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 154
2 47
3 2
4 12
5 45
6 33
7 38
8 5
9 36
10 11
11 254
12 69
13 6
14 8
15 22

About Hideyuki Tozaki

Hideyuki Tozaki is a scholar working on Pharmaceutical Science, Gastroenterology and Endocrinology, Diabetes and Metabolism, having authored 15 papers that have together received 742 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (8 papers), Inflammatory Bowel Disease (5 papers) and Drug Solubulity and Delivery Systems (5 papers). The work is most often cited by research in Pharmaceutical Science (490 citations), Gastroenterology (111 citations) and Molecular Medicine (64 citations). Hideyuki Tozaki has collaborated with scholars based in Japan and United States. Frequent co-authors include Shozo Muranishi, Akira Yamamoto, Akira Terabe, Takuya Fujita, Tsutomu Suzuki, Junta Komoike, Susumu Okabe, Takako Maruyama, Chika Tada and Naoki Okada. Their work appears in journals such as Journal of Controlled Release, Life Sciences and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026